Risk of Cardiovascular Events in Patients with Osteoporosis on Romosozumab Treatment Compared with Denosumab: A Multicenter Observational Cohort Study

Endocrinology and Metabolism · Published 2026-05-15 · DOI 10.3803/enm.2026.2883

Free full text

Authors (9)

Seong Hee Ahn, Dachung Boo, Kyoung Jin Kim, Jimi Choi, Hyemin Yoon, Chai Young Jung, Seng Chan You, Ji Seon Oh, Namki Hong

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Ahn, S., Boo, D., Kim, K., et al. (2026). Risk of Cardiovascular Events in Patients with Osteoporosis on Romosozumab Treatment Compared with Denosumab: A Multicenter Observational Cohort Study. Endocrinology and Metabolism. https://doi.org/10.3803/enm.2026.2883

Related articles